|
|
|
|
|
By Mitch Raith, Teva Global R&D | Improving specific productivity moves the goal beyond pumping out higher titers, but it demands a deeper understanding of cellular biology and protein expression. | |
|
|
|
By Victor Lien, Ph.D., PMP | Effective mAb and antibody-drug conjugate (ADC) manufacturing control strategies evolve through the phases. These four principles should guide your strategy design as goals shift. | |
|
|
|
Antti Aalto, Ph.D., VTT Technical Research Centre of Finland | Trichoderma reesei has powered the food sector for decades. Explore the strategic shift of moving this robust organism into the regulated world of biopharmaceutical protein manufacturing. | |
|
|
